While clinical trials show adults on the highest dose of Zepbound lose an average of 22.5% of their body weight after 72 weeks (when paired with diet and exercise), recent Phase 3 trial data (from the TRIUMPH-1 study released in May 2026) shows even better results
l-Arginine, which is converted to nitric oxide via nitric oxidase, stimulates the production of GLP-1, and dysregulation of l-arginine in obese patients leads to increased risk of airway inflammation and bronchoconstriction [85]
These capsules have no animal products and are suited to people on a vegan or vegetarian diet
Hyaluronic acid hydrates the skin and prevents dryness, while panthenol soothes and sodium PCA strengthens the skin barrier
Explore MOTS-c Mitochondrial, metabolic, and training-response support
Which GLP-1 Medications Are Available